Allu Arjun 'Pushpa 2: The Rule' crosses $1.20 MILLION in North America pre-sales ahead of December premiere

Allu Arjun’s highly anticipated action drama 'Pushpa 2: The Rule' has hit a major milestone, surpassing the $1 million in pre-sales for its North American premiere.

With two weeks still to go before its release on December 4, the film has generated immense buzz among fans. According to Venky Box Office, the movie has already raked in an estimated $1.208 million in advance ticket sales, selling over 40,000 tickets across 850 locations.

See more: 'Pushpa 2: The Rule' box office collection Day 2 early estimates

Sacnilk.com reports that the film has already set a record as the fastest Indian movie to hit $1 million in pre-sales for its premiere. Advance bookings for 'Pushpa 2' opened a month in advance. While bookings opened on a strong start, it slowed down a bit before gaining momentum again after the trailer release on November 17. With the release date drawing close, sales are expected to rise further with trade experts predicting that the film could even deliver one of the biggest openings for an Indian film in North America.

See more: Pushpa 2: The Rule Movie Review



See more: ‘Pushpa 2’ box office collections day 1

Pushpa 2 is poised to compete with some of the highest-grossing Indian films in North America, including Baahubali 2: The Conclusion ($20.77 million), Kalki 2898 AD ($18.57 million), Pathaan ($17.45 million), Jawan ($15.23 million), and RRR ($15.15 million). With its current trajectory, it could potentially claim a spot among these blockbusters.Directed by Sukumar, 'Pushpa 2' stars Allu Arjun, Rashmika Mandanna, and Fahadh Faasil in pivotal roles. Scheduled for release on December 5 in multiple Indian languages, the film serves as a sequel to the 2021 hit 'Pushpa: The Rise'.

See More: Pushpa 2 Movie Review and release LIVE Updates
Stay updated with the latest entertainment news on Times of India. Don't miss the Pushpa 2 review, showtimes, box office collection, estimates and live updates.